21.47 USD
+3.38 (+18.68%)
21.48 USD
+0.01 (+0.05%)
ChartMill assigns a Buy % Consensus number of 85% to NRIX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 27.72. This target is 29.11% above the current price.
NRIX was analyzed by 23 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about NRIX.
In the previous month the buy percentage consensus was at a similar level.
NRIX was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-08 | Needham | Reiterate | Buy -> Buy |
| 2025-11-04 | BTIG | Reiterate | Buy -> Buy |
| 2025-11-04 | Needham | Reiterate | Buy -> Buy |
| 2025-10-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-23 | BTIG | Maintains | Buy -> Buy |
| 2025-10-23 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-22 | Needham | Maintains | Buy -> Buy |
| 2025-10-21 | Mizuho | Initiate | Outperform |
| 2025-10-20 | Needham | Reiterate | Buy -> Buy |
| 2025-10-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-10-14 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-10 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-10-10 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-31 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2025-07-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-10 | UBS | Maintains | Buy -> Buy |
| 2025-07-10 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-07-10 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2025-04-29 | Needham | Reiterate | Buy -> Buy |
| 2025-04-09 | Needham | Maintains | Buy -> Buy |
| 2025-04-09 | Stifel | Maintains | Buy -> Buy |
| 2025-04-09 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-17 | Leerink Partners | Initiate | Market Perform |
| 2025-02-03 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-29 | Needham | Maintains | Buy -> Buy |
| 2025-01-29 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-01-29 | Stifel | Maintains | Buy -> Buy |
NURIX THERAPEUTICS INC / NRIX FAQ
What is the average price target for NURIX THERAPEUTICS INC (NRIX) stock?
23 analysts have analysed NRIX and the average price target is 27.72 USD. This implies a price increase of 29.11% is expected in the next year compared to the current price of 21.47.
Can you provide the consensus rating for NURIX THERAPEUTICS INC stock?
The consensus rating for NURIX THERAPEUTICS INC (NRIX) is 85.2174 / 100 . This indicates that analysts generally have a positive outlook on the stock.